SLC29A1 Produkte
(Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1))
Kategorien
This gene is a member of the equilibrative nucleoside transporter family. The gene encodes a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte SLC29A1 Kategorien
SLC29A1 Antikörper
High quality antibodies with extensive validation data.
SLC29A1 ELISA Kits
Reliable ELISA kits for a wide range of species.
SLC29A1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene SLC29A1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human, Mouse
Applikation
WB, IHC (p), FACS
Validierungen
- (3)
- (5)
Kat. Nr.
ABIN387940
Menge
400 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, ELISA, IHC, IF
Validierungen
- (3)
Kat. Nr.
ABIN7151966
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human, Mouse
Applikation
WB
Validierungen
- (2)
- (2)
Kat. Nr.
ABIN387941
Menge
200 μL
Datenblatt
Datenblatt
Empfohlene SLC29A1 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6970331
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Mouse
Analytical Method
Validierungen
Kat. Nr.
ABIN1132220
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Rat
Analytical Method
Validierungen
Kat. Nr.
ABIN1132221
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene SLC29A1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
- (1)
Kat. Nr.
ABIN1778128
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
- (1)
Kat. Nr.
ABIN2732169
Menge
20 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren SLC29A1 Produkten
: "Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine." in: Nature, (2022) (PubMed).: "In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer ..." in: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, (2017) (PubMed).
: "Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5." in: Oncotarget, Vol. 8, Issue 7, pp. 11748-11762, (2017) (PubMed).
: "SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia." in: Cancer chemotherapy and pharmacology, Vol. 78, Issue 3, pp. 533-40, (2016) (PubMed).
: "Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated ..." in: British journal of cancer, Vol. 111, Issue 7, pp. 1275-84, (2014) (PubMed).
: "Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. ..." in: Journal of the National Cancer Institute, Vol. 106, Issue 1, pp. djt347, (2014) (PubMed).
: "Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in ..." in: Surgery, Vol. 153, Issue 4, pp. 565-75, (2013) (PubMed).
: "Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine ..." in: Annals of surgical oncology, Vol. 19 Suppl 3, pp. S646-55, (2012) (PubMed).
: "Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. ..." in: The Journal of clinical investigation, Vol. 122, Issue 2, pp. 693-710, (2012) (PubMed).
: "Host-based ribavirin resistance influences hepatitis C virus replication and treatment response." in: Journal of virology, Vol. 85, Issue 14, pp. 7273-83, (2011) (PubMed).
Synonyme und alternative Namen zu SLC29A1
solute carrier family 29 member 1 (Augustine blood group) (SLC29A1), solute carrier family 29 member 1 (Slc29a1), solute carrier family 29 (nucleoside transporters), member 1 (Slc29a1), 1200014D21Rik, AA407560, ENT1, rENT1Bezeichner auf Proteinebene für SLC29A1
- equilibrative NBMPR-sensitive nucleoside transporter
- equilibrative nitrobenzylmercaptopurine riboside (NBMPR)-sensitive nucleoside transporter
- equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter
- equilibrative nucleoside transporter 1
- nucleoside transporter, es-type
- solute carrier family 29 (nucleoside transporters), member 1
- solute carrier family 29 member 1
- solute carrier family 29, member 1
- NBMPR-sensitive equilibrative nucleoside transporter
- equilibrative nucleoside transporter 1 variant delta 11
Sie sind hier:
